Three years after his death, cricketer Shane Warne's legacy lives on with heart health checks
Warne died in March 2022 after suffering cardiac arrest while on holiday on the Thai island of Koh Samui.
The cause of his sudden death led his business team and family to unite to honor his life and create Shane Warne Legacy. The charity set up free heart health checkup machines at the Melbourne Cricket Ground during the past two Boxing Day tests.
The results of the stadium checks along with 311 community pharmacy stations across Australia were analyzed as part of a Monash University-led study. A total of 76,085 people were screened across seven weeks from mid-December 2023 to the end of January 2024, including 7,740 at the MCG.
The research published in the Journal of the American College of Cardiology on Friday showed almost seven out of 10 (68.9%) had at least one uncontrolled risk factor for heart disease. Factors were elevated blood pressure readings (37.2%), elevated body mass index (60.5%) and being a smoker (12.1%).
Cricket spectators who did the free checks, mostly men aged 35 to 64, had higher rates of elevated blood pressure and body mass index than those screened at pharmacies.
Warne revived and elevated the art of leg-spin bowling when he emerged on the international scene in the 1990s and was a central character in one of Australia's most successful eras in the sport. He also was one of cricket's larger-than-life showmen.
Warne held the record for the most test wickets with 708 when he retired in 2007 after his 145th match. Only Sri Lanka off-spinner Muttiah Muralitharan has passed him, with 800.
'Meeting people where they are, whether that's at their local pharmacy or the MCG, can make all the difference to health outcomes,' said Dr. Sean Tan, a cardiologist and researcher at the Victorian Heart Institute.
Warne's long-time personal assistant Helen Nolan said the findings reinforced Shane Warne Legacy's mission to turn his death into a catalyst for change. The charity's chief executive described the results as 'bittersweet.'
'We're proud to have helped thousands take their heart health seriously but we know there's still work to do,' Nolan said. 'Shane would have wanted this to make a massive difference.'
___
AP cricket: https://apnews.com/hub/cricket
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 hours ago
- Yahoo
What Happens to Your Cholesterol When You Walk Every Day
Reviewed by Dietitian Maria Laura Haddad-Garcia Key Points Walking daily is one of the simplest low-barrier ways to support your overall heart health. Walking may help lower your LDL cholesterol and triglyceride levels and raise HDL cholesterol levels. Using weights, tracking your steps and walking post-meal are ways to make walking more effective. Trying to lower your cholesterol and support your heart health without hitting the gym? The good news is that you don't need a grueling fitness routine to make a difference in your cardiovascular health. Walking every day is a simple and accessible habit that can help improve your blood lipids (triglycerides, LDL or 'bad' and HDL or 'good' cholesterol levels) and protect your cardiovascular system in the long run. Why does this matter? 'High cholesterol is a major modifiable risk factor for the development of coronary artery disease,' says Bradley Serwer, M.D. 'By managing your cholesterol levels, you can potentially avoid or minimize heart attacks, strokes or peripheral vascular disease.' Your triglyceride levels are important, too. High triglycerides can happen on their own, but they can also go hand-in-hand with cholesterol levels, increasing your risk for heart disease. The Benefits of Walking for Cholesterol Daily walking delivers a range of benefits for cholesterol management and heart health. Here's an in-depth look at how it works. Lowers LDL Cholesterol When we talk about 'bad' cholesterol, we're referring to low-density lipoproteins or LDL, a waxy substance that can build up in your arteries. 'Elevated LDL increases the risk of heart attack and stroke by promoting plaque in critical vessels, particularly those of the heart and brain,' explains Alan Rozanski, M.D.. Research shows that for women with overweight or obesity, walking regularly for at least four weeks slightly lowers total cholesterol and 'bad' LDL cholesterol by about 7 mg/dL. Another study conducted on men found that consistent, moderate exercise for 12 weeks reduced LDL cholesterol by 5% to 7%. At the same time, more research on both men and women, ages 40 to 65, found that walking for three months or more produced mixed results, with some studies finding changes in cholesterol and triglyceride levels while others did not. While the effects may vary, incorporating regular walking into your routine is a simple and accessible way to support overall heart health. Supports Healthy HDL Cholesterol High-density lipoprotein (HDL) is often called the 'good' cholesterol because it removes cholesterol, protects against harmful oxidation, reduces inflammation and may help prevent blood clots. Higher levels of HDL are linked to lower risks of heart disease according to some (but not all) data. 'Aerobic activities such as walking help raise your high-density lipoprotein, HDL,' shares Serwer. Research shows that beyond just changing the numbers, exercise helps HDL particles mature and function better. Helps Lower Triglycerides Triglycerides are a type of fat in your blood, and elevated levels are another risk factor for cardiovascular disease. The good news? Walking is an effective way to lower them. During physical activity, your muscles use triglycerides as an energy source. Participating in physical activity, like walking, has been linked to reduced triglyceride concentrations in some studies. Supports Better Weight Management Walking is one of the simplest and most effective ways to support weight loss. It burns calories, supports metabolism and helps maintain lean muscle mass, all of which contribute to shedding extra pounds. Plus, it's an accessible and low-impact activity that can be easily incorporated into daily routines, making it a sustainable choice for long-term weight management. Carrying excess weight is closely linked to a range of heart-health concerns, including high cholesterol levels. People who carry extra body fat, particularly around the abdomen, tend to have higher LDL cholesterol levels. By making walking a regular habit, you can take a proactive step toward managing your weight and protecting your heart health. Helps Spark a Positive Feedback Loop Walking can also inspire a ripple effect of healthier choices. 'Walking can spark a positive feedback loop. As people become more active, they tend to feel better and adopt healthier habits—like improved eating—which further supports cholesterol management. That's why doctors often encourage movement as a starting point for lifestyle change,' explains Rozanski. This initial step toward activity often lays the groundwork for broader lifestyle improvements. By supporting energy levels and possibly improving mood, walking can make it easier to embrace other heart-healthy habits. Whether it's preparing more nutritious meals, getting better sleep or feeling motivated to try new activities, these changes work together to enhance overall health. Walking, therefore, isn't just exercise; it can be a catalyst for long-term, positive transformation. How Much Walking Do You Need? The Centers for Disease Control and Prevention recommends at least 150 minutes of moderate-intensity physical activity per week, which breaks down to about 30 minutes a day, five days a week. Brisk walking (about 3 to 4 miles per hour) fits the bill perfectly. If possible, aim for even more; 300 minutes weekly is linked to even greater heart benefits. 'But for the 25% of people who get no exercise at all, that can feel out of reach. The encouraging news is that even short bouts—like brisk five-minute walks—canimprove health,' says Rozanski. If you want to maximize results, adding some intensity can help. Try integrating inclines, walking at a faster pace, or even intervals where you alternate between slow and brisk walking. Tips to Make Walking Work for You Walking is simple, but a few tweaks can make it even more effective. Here are practical tips to make your daily walks count: Walk after meals to help with lipid metabolism. A 10- to 15-minute walk after eating can aid digestion and improve cholesterol processing. Add inclines or use hand weights for added cardio benefits. Walking uphill or using light weights engages more muscles and burns more fat. Track your steps with a pedometer or app to stay accountable and motivated. Many people find the goal of 10,000 steps a day achievable and rewarding. Pair your walking with . Start your day with oatmeal or snack on walnuts post-walk to double down on heart-health benefits. Small changes compound over time, so feel free to adjust these tips to your routine. Our Expert Take It's official! Walking daily is one of the simplest low-barrier ways to support your overall heart health. It's easy to incorporate into your lifestyle, whether that's a morning stroll, a post-dinner walk or active errands around town. Remember, you don't need fancy equipment, a big time commitment or extreme workouts. All it takes is lacing up your shoes and stepping outdoors. Starting small (like a 10-minute daily walk) can lead to big results over time. Your heart doesn't care how fast you go, just that you keep going. The sooner you start, the sooner your body and mind will feel the benefits. Take that first step today; your heart will thank you tomorrow. Read the original article on EATINGWELL
Yahoo
10 hours ago
- Yahoo
Radiopharm Theranostics Limited (RADX) Receives IND Approval From FDA To Initiate Phase I Therapeutic Clinical Study To Target B7H3 With Betabart (RV-01)
Radiopharm Theranostics Limited (NASDAQ:RADX) is among the 12 Best Australian Stocks to Buy Right Now. The company recently announced receiving Investigational New Drug (IND) approval from the FDA to begin a Phase 1 therapeutic clinical study to target B7H3 with Betabart (RV-01). A well-stocked pharmacy shelf full of the company's pharmaceuticals, nutraceuticals, over-the-counter medications, and health care products. The Lu-177-B7H3 monoclonal antibody is the first in class targeted radiopharmaceutical that is being developed against the 4lg type of B7H3. Radiopharm Theranostics Limited (NASDAQ:RADX) believes it has the potential to become a highly differentiated drug for treating individuals with aggressive solid tumors. The company says it is on track to initiate the first-in-human study during the fourth quarter of this calendar year. Findings from recent preclinical studies have shown that RV-01 exhibits hepatic clearance, which allows the isotope enough time to target tumors, while also potentially reducing adverse effects such as hematological toxicities. Moreover, these monoclonal antibodies are cleared by the liver, unlike peptides and small molecules. This, coupled with the shortened half-life of RV-01, makes this agent stand out compared to other monoclonal antibodies and targeted radiotherapeutics with a renal excretion pathway. Radiopharm Theranostics Limited (NASDAQ:RADX) is an Australia-based clinical-stage radiotherapeutics firm developing innovative radiopharmaceutical products for therapeutic and diagnostic applications in areas of high unmet medical need. While we acknowledge the potential of RADX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 11 Best Large Cap Defense Stocks to Buy According to Analysts and 10 Best Low Priced Defense Stocks to Buy Now. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
10 hours ago
- Yahoo
Incannex Healthcare Inc. (IXHL) Receives Positive Patient-Reported Outcomes For IHL-42X in Obstructive Sleep Apnoea
Incannex Healthcare Inc. (NASDAQ:IXHL) is among the 12 Best Australian Stocks to Buy Right Now. On August 8, the company announced positive new patient-reported outcomes from participants in its RePOSA Phase 2 trial of IHL-42X to treat obstructive sleep apnoea (OSA). A scientist in a lab coat examining a Petri dish containing a biopharmaceutical culture. The new insights were collected through exit interviews, in line with FDA's guidance on Patient-Focused Drug Development (PFDD). The results build on already compelling data to reinforce the potential of IHL-42X to improve sleep quality, cognitive function, and daily life. Incannex Healthcare Inc. (NASDAQ:IXHL) said that 57.6% of the respondents reported an improvement in their OSA, of which 89.5% described it as a meaningful change to their lives. Some of the reported benefits include better sleep quality, reduced sleepiness during the daytime, feeling fresh in the morning, and other cognitive and daily-life improvements. Joel Latham, President and CEO of Incannex Healthcare Inc. (NASDAQ:IXHL) stated the following on the findings: 'Our recent Phase 2 results for IHL-42X exceeded expectations. In some patients, we observed reductions in AHI of up to 83%, which is an extraordinary outcome and a powerful signal of the drug's potential. We believe the findings from the patient exit interviews underscore that these improvements are not just clinical—they are translating into meaningful, positive changes in patients' daily lives. This reinforces our belief that IHL-42X has the potential to significantly shift the treatment paradigm for OSA.' Incannex Healthcare Inc. (NASDAQ:IXHL) is a clinical-stage pharmaceutical company developing medicines to treat chronic conditions, including obstructive sleep apnea, generalized anxiety disorder, and rheumatoid arthritis. While we acknowledge the potential of IXHL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 11 Best Large Cap Defense Stocks to Buy According to Analysts and 10 Best Low Priced Defense Stocks to Buy Now. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
